Intestinal Microbiome in Dogs with Chronic Hepatobiliary Disease: Can We Talk about the Gut-Liver Axis?

被引:7
作者
Habermaass, Verena [1 ]
Olivero, Daniela [2 ]
Gori, Eleonora [1 ]
Mariti, Chiara [1 ]
Longhi, Erika [3 ]
Marchetti, Veronica [1 ]
机构
[1] Univ Pisa, Dept Vet Sci, Via Livornese Lato Monte, I-56122 Pisa, Italy
[2] Anal Lab BSA Scilvet, Via A Aosta 7, I-20129 Milan, Italy
[3] Anal Lab Labospace, Via Apelle 41, I-20128 Milan, Italy
关键词
canine microbiota; gut microbiota; dysbiosis; hepatopathy; canine hepatic disease; liver-gut axis; BILE-ACIDS; FECAL MICROBIOTA; CATS; METABOLISM; CANINE; DIET;
D O I
10.3390/ani13203174
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Simple Summary The interaction between gut and liver is currently considered for the management of humans with chronic hepatobiliary disease (CHD). The gut microbiota (GM) is considered to strongly mediate this crosstalk. The present study aimed to evaluate the GM in dogs diagnosed with CHD. Comparison among CHD dogs were made with respect to some clinical and biochemical variables. Sixty-five dogs were prospectively enrolled. Clinical and hematobiochemical evaluation together with GM sequencing was performed. Several GM modifications were observed, with cholestasis apparently associated with deeper GM alteration. For the management of dogs with CHD and especially cholestatic CHD, clinicians should be aware that gut-liver interaction may lead to dysbiosis.Abstract The gut-liver axis represents a current topic in human medicine. Extensive research investigates the gut microbiome (GM) modifications in relation to various kinds of chronic hepatobiliary diseases (CHD), with many mechanisms and therapeutical implications recognized. Those aspects in veterinary medicine are still quite unexplored. The aim of the present study was to evaluate GM in dogs diagnosed with CD. Comparison among CHD dogs were made considering some clinical and biochemical variables (lipemia and alanine-aminotransferase activities), presence of cholestasis or endocrine disorders, diet). Sixty-five dogs were prospectively enrolled with clinical and hematobiochemical evaluation and 16S-RNA GM sequencing assessed. Dogs that received antibiotics and/or pre/pro/symbiotics administration were excluded. Deeper GM alteration was observed between dogs with or without ultrasonographic and biochemical cholestatic CHD. Cholestasis was associated with a decrease in several bacterial taxa, including Clostridium hiranonis, Fusobacterium, Megamonas, Ruminococcus faecis, Turicibacter, and higher levels of Escherichia/Shigella and Serratia. Thus, the alteration in bile flow and composition, typical of cholestasis, may directly affect the local intestinal microbial environment. For the management of dogs with CHD and especially cholestatic CHD, clinicians should be aware that gut-liver interaction may lead to dysbiosis.
引用
收藏
页数:20
相关论文
共 50 条
[41]   Effects of Synbiotic Administration on Gut Microbiome and Fecal Bile Acids in Dogs with Chronic Hepatobiliary Disease: A Randomized Case-Control Study [J].
Habermaass, Verena ;
Biolatti, Corrado ;
Bartoli, Francesco ;
Gori, Eleonora ;
Bruni, Natascia ;
Olivero, Daniela ;
Marchetti, Veronica .
VETERINARY SCIENCES, 2024, 11 (08)
[42]   Gut-liver axis in liver disease: From basic science to clinical treatment (Review) [J].
Wang, Jianpeng ;
Wang, Xinyi ;
Zhuo, Enba ;
Chen, Bangjie ;
Chan, Shixin .
MOLECULAR MEDICINE REPORTS, 2025, 31 (01)
[43]   Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut-Liver Axis Theory [J].
Li, Shipeng ;
Han, Wenfeng ;
He, Qichen ;
Zhang, Wei ;
Zhang, Youcheng .
CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
[44]   From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease [J].
Zhou, Mi ;
Lv, Jianyu ;
Chen, Xinli ;
Shi, Yujie ;
Chao, Guanqun ;
Zhang, Shuo .
ANNALS OF HEPATOLOGY, 2025, 30 (01)
[45]   Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis [J].
Zhu, Weifeng ;
Zhou, Ying ;
Tsao, Rong ;
Dong, Huanhuan ;
Zhang, Hua .
FRONTIERS IN NUTRITION, 2022, 9
[46]   Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist [J].
Moon, An-Na ;
Breyner, Natalia ;
Song, Dong-Keun ;
Madsen, Martin R. onn ;
Kim, Hongbin ;
Choi, Keonwoo ;
Lee, Yoonsuk ;
Namkung, Wan .
BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
[47]   Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers [J].
Gil-Gomez, Antonio ;
Brescia, Paola ;
Rescigno, Maria ;
Romero-Gomez, Manuel .
SEMINARS IN LIVER DISEASE, 2021, 41 (02) :191-205
[48]   Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease [J].
Ma, Chi ;
Yang, Juan ;
Fu, Xin-Nian ;
Luo, Jiang-Yan ;
Liu, Pei ;
Zeng, Xue-Li ;
Li, Xin-Yi ;
Zhang, Shun-Ling ;
Zheng, Sheng .
WORLD JOURNAL OF HEPATOLOGY, 2025, 17 (05)
[49]   Rosa rugosa polysaccharide attenuates alcoholic liver disease in mice through the gut-liver axis [J].
Li, Hailong ;
Xie, Ziyang ;
Zhang, Yao ;
Liu, Yue ;
Niu, Aijing ;
Liu, Yingying ;
Zhang, Linbo ;
Guan, Lili .
FOOD BIOSCIENCE, 2021, 44
[50]   Acanthopanax seeds polysaccharide improve alcoholic fatty liver disease through the gut-liver axis [J].
Qin, Liwen ;
Piao, Hongjie ;
Song, Cuiyu ;
Tang, Lingyue ;
Yang, Xiao ;
Wen, Yuping ;
Cui, Hushan ;
Jin, Qing .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 301